4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-18-006817
Chief Financial Officer acquired 5,230 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tulipano Stephen J Chief Financial Officer | 2017-06-30 | Grant or award | +2,077 | $3.95 | $8,209 | 5,410 | D |
| Tulipano Stephen J Chief Financial Officer | 2017-12-29 | Grant or award | +3,153 | $4.00 | $12,596 | 8,563 | D |
| Derivatives | |||||||
| Tulipano Stephen J Chief Financial Officer | 2018-03-06 | Grant or award · Employee Stock Option (Right to Buy) | +125,670 | 125,670 | D | ||
Loading xslF345X03/doc4.xml…